133 related articles for article (PubMed ID: 34670707)
21. Humoral response to West Nile virus vaccination in alpacas and llamas.
Kutzler MA; Baker RJ; Mattson DE
J Am Vet Med Assoc; 2004 Aug; 225(3):414-6. PubMed ID: 15328718
[TBL] [Abstract][Full Text] [Related]
22. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
Kitai Y; Kondo T; Konishi E
J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
[TBL] [Abstract][Full Text] [Related]
23. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
Davidson AH; Traub-Dargatz JL; Rodeheaver RM; Ostlund EN; Pedersen DD; Moorhead RG; Stricklin JB; Dewell RD; Roach SD; Long RE; Albers SJ; Callan RJ; Salman MD
J Am Vet Med Assoc; 2005 Jan; 226(2):240-5. PubMed ID: 15706975
[TBL] [Abstract][Full Text] [Related]
24. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
[TBL] [Abstract][Full Text] [Related]
25. Monitoring Anti-NS1 Antibodies in West Nile Virus-Infected and Vaccinated Horses.
Rebollo B; Sarraseca J; Lecollinet S; Abouchoaib N; Alonso J; García-Bocanegra I; Sanz AJ; Venteo Á; Jiménez-Clavero MA
Biomed Res Int; 2018; 2018():8309816. PubMed ID: 30356362
[TBL] [Abstract][Full Text] [Related]
26. Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination.
Joó K; Bakonyi T; Szenci O; Sárdi S; Ferenczi E; Barna M; Malik P; Hubalek Z; Fehér O; Kutasi O
Vet Immunol Immunopathol; 2017 Jan; 183():1-6. PubMed ID: 28063471
[TBL] [Abstract][Full Text] [Related]
27. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
[TBL] [Abstract][Full Text] [Related]
28. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
29. West Nile Virus: is a vaccine needed?
Martina BE; Koraka P; Osterhaus AD
Curr Opin Investig Drugs; 2010 Feb; 11(2):139-46. PubMed ID: 20112163
[TBL] [Abstract][Full Text] [Related]
30. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
[TBL] [Abstract][Full Text] [Related]
31. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
[TBL] [Abstract][Full Text] [Related]
32. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.
Kitai Y; Shirafuji H; Kanehira K; Kamio T; Kondo T; Konishi E
Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1093-8. PubMed ID: 21254919
[TBL] [Abstract][Full Text] [Related]
33. Equine seroprevalence of West Nile virus antibodies in the UK in 2019.
Folly AJ; Waller ESL; McCracken F; McElhinney LM; Roberts H; Johnson N
Parasit Vectors; 2020 Nov; 13(1):596. PubMed ID: 33243297
[TBL] [Abstract][Full Text] [Related]
34. [Surveillance of West Nile fever in horses in the Czech Republic from 2011 to 2013].
Sedlák K; Zelená H; Křivda V; Šatrán P
Epidemiol Mikrobiol Imunol; 2014 Nov; 63(4):307-11. PubMed ID: 25523225
[TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.
Balasuriya UB; Shi PY; Wong SJ; Demarest VL; Gardner IA; Hullinger PJ; Ferraro GL; Boone JD; De Cino CL; Glaser AL; Renshaw RW; Ledizet M; Koski RA; MacLachlan NJ
J Vet Diagn Invest; 2006 Jul; 18(4):392-5. PubMed ID: 16921881
[TBL] [Abstract][Full Text] [Related]
36. First Serological Evidence of West Nile Virus in Horses and Dogs from Corsica Island, France.
Maquart M; Dahmani M; Marié JL; Gravier P; Leparc-Goffart I; Davoust B
Vector Borne Zoonotic Dis; 2017 Apr; 17(4):275-277. PubMed ID: 28075236
[TBL] [Abstract][Full Text] [Related]
37. West Nile virus infection of Thoroughbred horses in South Africa (2000-2001).
Guthrie AJ; Howell PG; Gardner IA; Swanepoel RE; Nurton JP; Harper CK; Pardini A; Groenewald D; Visage CW; Hedges JF; Balasuriya UB; Cornel AJ; MacLachlan NJ
Equine Vet J; 2003 Sep; 35(6):601-5. PubMed ID: 14515962
[TBL] [Abstract][Full Text] [Related]
38. A review of vaccine approaches for West Nile virus.
Iyer AV; Kousoulas KG
Int J Environ Res Public Health; 2013 Sep; 10(9):4200-23. PubMed ID: 24025396
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
[TBL] [Abstract][Full Text] [Related]
40. High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection.
Nielsen CF; Reisen WK; Armijos MV; Maclachlan NJ; Scott TW
Am J Trop Med Hyg; 2008 Jan; 78(1):45-52. PubMed ID: 18187784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
